Notably, the NOP56–FBL interaction or their involvement in ribosome biogenesis-related oncogenic pathways has also been observed in other malignancies, such as colorectal cancer and breast cancer, suggesting that this regulatory axis may represent a more universal cancer-promoting mechanism rather than one restricted to HCC (42). The gene discussed is NOP56; the disease is breast cancer.